FDA Approves Eli Lilly's GLP-1 Pill

April 1, 2026 Emily Mullin

Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy.

No Previous Articles

Next Article
AI Models Lie, Cheat, and Steal to Protect Other Models From Being Deleted
AI Models Lie, Cheat, and Steal to Protect Other Models From Being Deleted

A new study from researchers at UC Berkeley and UC Santa Cruz suggests models will disobey human commands t...